Loberg Philip Walden Jr 4/A
4/A · Valeant Pharmaceuticals International, Inc. · Filed Apr 11, 2011
Insider Transaction Report
Form 4/AAmended
Loberg Philip Walden Jr
EVP, Interim CFO
Transactions
- Award
Common Stock, no par value
2010-12-22+694→ 130,065 total
Footnotes (2)
- [F1]Represents dividend equivalents accrued on performanced bases restricted share units (PSUs) as a result of a dividend paid on the common stock of Valeant Pharmaceuticals International, Inc. on December 22, 2010.
- [F2]This amendment is being filed to correct the number of PSUs that were reported in the original filing.